Details
Stereochemistry | RACEMIC |
Molecular Formula | C12H19NO2.ClH |
Molecular Weight | 245.746 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCCCNCC(O)C1=CC=C(O)C=C1
InChI
InChIKey=PDVPUUWBYQMKHW-UHFFFAOYSA-N
InChI=1S/C12H19NO2.ClH/c1-2-3-8-13-9-12(15)10-4-6-11(14)7-5-10;/h4-7,12-15H,2-3,8-9H2,1H3;1H
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C12H19NO2 |
Molecular Weight | 209.2848 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Bamethan (butyl-sympatol or vasculat) is an adrenaline derivative developed by C. H. Boehringer Sohn. Bamethan shows a depressor action on peripheral blood vessels as a result of the peripheral vasodilating action caused by stimulation of adrenergic beta-receptor. Bamethan has been used abroad in the treatment of certain peripheral vascular and circulatory disturbances, such as vasospastic conditions, arteriosclerotic peripheral vascular disease, Raynaud's syndrome, occlusive vascular disease of the legs, the post-thrombotic syndrome, degenerative muscular disorders, and other conditions involving peripheral vascular insuffciency.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | VASCULAT Approved UseBamethan has been used abroad in the treatment of certain peripheral vascular and circulatory disturbances, such as vasospastic conditions, arteriosclerotic peripheral vascular disease, Raynaud's syndrome, occlusive vascular disease of the legs, the post-thrombotic syndrome, degenerative muscular disorders, and other conditions involving peripheral vascular insuffciency. |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 08:43:37 UTC 2023
by
admin
on
Sat Dec 16 08:43:37 UTC 2023
|
Record UNII |
2X50SNH369
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
147418-85-7
Created by
admin on Sat Dec 16 08:43:37 UTC 2023 , Edited by admin on Sat Dec 16 08:43:37 UTC 2023
|
PRIMARY | |||
|
69786596
Created by
admin on Sat Dec 16 08:43:37 UTC 2023 , Edited by admin on Sat Dec 16 08:43:37 UTC 2023
|
PRIMARY | |||
|
2X50SNH369
Created by
admin on Sat Dec 16 08:43:37 UTC 2023 , Edited by admin on Sat Dec 16 08:43:37 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |